René Raaijmakers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
René Raaijmakers has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Bert G. Blijenberg
From the Departments of Urology (RR, MFW, MJR, FHS) and Clinical Chemistry (BGB), Erasmus MC, Rotterdam, The Netherlands, and Hybritech, Inc., a subsidiary of Beckman Coulter, Inc. (JAF, HGR), San Diego, California
1 shared publicationFritz H. Schröder
From the Departments of Urology (RR, MFW, MJR, FHS) and Clinical Chemistry (BGB), Erasmus MC, Rotterdam, The Netherlands, and Hybritech, Inc., a subsidiary of Beckman Coulter, Inc. (JAF, HGR), San Diego, California
1 shared publicationHarry G. Rittenhouse
From the Departments of Urology (RR, MFW, MJR, FHS) and Clinical Chemistry (BGB), Erasmus MC, Rotterdam, The Netherlands, and Hybritech, Inc., a subsidiary of Beckman Coulter, Inc. (JAF, HGR), San Diego, California
1 shared publicationJudith A. Finlay
From the Departments of Urology (RR, MFW, MJR, FHS) and Clinical Chemistry (BGB), Erasmus MC, Rotterdam, The Netherlands, and Hybritech, Inc., a subsidiary of Beckman Coulter, Inc. (JAF, HGR), San Diego, California
1 shared publicationMark F. Wildhagen
From the Departments of Urology (RR, MFW, MJR, FHS) and Clinical Chemistry (BGB), Erasmus MC, Rotterdam, The Netherlands, and Hybritech, Inc., a subsidiary of Beckman Coulter, Inc. (JAF, HGR), San Diego, California
1 shared publication- Monique J. Roobol
Department of Urology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands
1 shared publication
Latest Publications
- 1 June 2004
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (6 Part 1) , 2245-2249
PROSTATE CANCER DETECTION IN THE PROSTATE SPECIFIC ANTIGEN RANGE OF 2.0 TO 3.9 NG/ML: VALUE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN ON TUMOR DETECTION AND TUMOR AGGRESSIVENESS
Purpose: We evaluated the positive predictive value and cancer detection rate in the prostate specific antigen (PSA) range of 2.0 to 3.9 ng/ml and assessed the value of percent free (F) PSA...
- 1 June 2004
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (6 Part 1) , 2245-2249
PROSTATE CANCER DETECTION IN THE PROSTATE SPECIFIC ANTIGEN RANGE OF 2.0 TO 3.9 NG/ML: VALUE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN ON TUMOR DETECTION AND TUMOR AGGRESSIVENESS
Purpose: We evaluated the positive predictive value and cancer detection rate in the prostate specific antigen (PSA) range of 2.0 to 3.9 ng/ml and assessed the value of percent free (F) PSA...